ArticlePloS one2024

Vorolanib, sunitinib, and axitinib: A comparative study of vascular endothelial growth factor receptor inhibitors and their anti-angiogenic effects.

Sophie J Bakri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.